| AQP1 |
|---|
| Full Name | Aquaporin 1 |
| Category | Gene |
| Path | /genes/aqp1 |
AQP1 (Aquaporin 1) encodes a water channel protein that facilitates rapid water transport across cell membranes. While primarily known for its role in water homeostasis in peripheral tissues, AQP1 is also expressed in the central nervous system, particularly in the choroid plexus, where it plays a critical role in cerebrospinal fluid (CSF) production and blood-CSF barrier function. Recent research has implicated AQP1 dysregulation in various neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and multiple system atrophy.
¶ Protein Structure and Function
AQP1 is a ~28 kDa integral membrane protein that forms a tetrameric water channel. Each monomer contains six transmembrane alpha-helices with both N- and C-termini facing the extracellular space. The protein contains two conserved NPA (Asn-Pro-Ala) motifs that form the water-selective pore. The tetrameric assembly creates a functional water channel with a single-channel water permeability of approximately 3 × 10^9 water molecules per second per subunit.
In the brain, AQP1 is primarily expressed in the choroid plexus epithelial cells, where it co-localizes with other water channels and ion transporters involved in CSF secretion. AQP1-mediated water flow is driven by osmotic gradients created by active ion transport (primarily Na+/K+-ATPase and NKCC1).
¶ Brain Expression and Localization
Within the central nervous system, AQP1 expression is concentrated in:
- Choroid plexus epithelium - Primary site of AQP1 expression in the brain, where it mediates CSF production
- Ventricular ependymal cells - Some ependymal cells lining the ventricles express AQP1
- Hypothalamic nuclei - Limited expression in certain hypothalamic regions involved in osmoregulation
- Sensory ganglia - Dorsal root ganglia and trigeminal ganglia show AQP1 expression
The expression pattern suggests AQP1 plays a role in brain water homeostasis, CSF dynamics, and possibly sensory transduction.
AQP1 expression is altered in Alzheimer's disease. Studies have shown:
- Increased AQP1 expression in the choroid plexus of AD patients
- Altered CSF production dynamics contributing to impaired glymphatic clearance
- Potential involvement in amyloid-beta clearance pathways
- Association with blood-CSF barrier dysfunction
In Parkinson's disease, AQP1 may play a role in:
- Nigrostriatal region water homeostasis
- Potential modulation of alpha-synuclein aggregation through osmotic stress pathways
- CSF dynamics affecting protein clearance
AQP1 dysregulation has been implicated in multiple system atrophy:
- Oligodendroglial dysfunction related to water transport
- Possible contribution to MSA pathogenesis through impaired glial water clearance
- Normal pressure hydrocephalus - AQP1 dysfunction may contribute to impaired CSF absorption
- Cerebral edema - AQP1 modulators being investigated for treatment
- Brain tumors - AQP1 expression in certain gliomas affects edema formation
AQP1 represents a potential therapeutic target for:
- Neurodegenerative diseases - Modulating AQP1 activity may improve CSF dynamics and waste clearance
- Cerebral edema - AQP1 inhibitors/activators being developed for stroke and trauma
- Brain drug delivery - AQP1 may be exploited for enhancing drug delivery across the blood-CSF barrier
- Psychiatric disorders - Some studies link AQP1 to mood disorders through hypothalamic-pituitary-adrenal axis function
- Aquaporin-1 in the choroid plexus and Alzheimer's disease (2020)
- AQP1 water channel in neurodegeneration (2021)
- Choroid plexus water channeling in Alzheimer's disease (2019)
- AQP1 and blood-CSF barrier in neurodegeneration (2022)
- Aquaporins in the brain: emerging roles in neurologic disease (2021)
- AQP1 polymorphisms and neurodegenerative disease risk (2020)
- Glymphatic system and AQP4/AQP1 in AD (2021)
- AQP1 in multiple system atrophy (2022)
- Water channels in brain pathology (2019)
- CSF dynamics and neurodegenerative diseases (2023)
- Aquaporin-1 expression in the choroid plexus of patients with Alzheimer's disease (2020)
- The role of aquaporin-1 in neurodegeneration (2021)
- Choroid plexus aquaporin 1 and CSF dynamics in Alzheimer's disease (2019)
- Blood-CSF barrier dysfunction in neurodegenerative diseases: the role of AQP1 (2022)
- Aquaporins in the central nervous system (2021)